Assessing the magnitude of antiemetic benefit with the addition of the NK1 receptor antagonist (NK1) aprepitant for all platinum agents: Analysis of 1,872 patients (pts) in prospective randomized clinical phase III trials (RCTs).

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 9057-9057 ◽  
Author(s):  
R. J. Gralla ◽  
B. L. Rapoport ◽  
K. Jordan ◽  
J. C. Street ◽  
A. Carides
2002 ◽  
Vol 133 (2) ◽  
pp. 363-368 ◽  
Author(s):  
Conrad Gentsch ◽  
Margaret Cutler ◽  
Annick Vassout ◽  
Siem Veenstra ◽  
Felix Brugger

1993 ◽  
Vol 249 (1-2) ◽  
pp. R3-R4 ◽  
Author(s):  
Chaz Bountra ◽  
Keith Bunce ◽  
Timothy Dale ◽  
Christopher Gardner ◽  
Christopher Jordan ◽  
...  

2012 ◽  
Vol 684 (1-3) ◽  
pp. 64-70 ◽  
Author(s):  
Suneeta Tumati ◽  
Tally M. Largent-Milnes ◽  
Attila I. Keresztes ◽  
Takashi Yamamoto ◽  
Todd W. Vanderah ◽  
...  

Epilepsia ◽  
2010 ◽  
Vol 51 (8) ◽  
pp. 1543-1551 ◽  
Author(s):  
Mikhail Kalinichev ◽  
Andrea Bradford ◽  
Silvia Bison ◽  
Adam Lucas ◽  
Ilaria Sartori ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document